Highlights
1. Elevated baseline growth differentiation factor-15 (GDF-15) is associated with increased risk of venous thromboembolism (VTE) in cancer patients.
2. N-terminal pro-B-type natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) are linked to higher bleeding risk.
